| First Author | Chakrabarty P | Year | 2015 |
| Journal | Neuron | Volume | 85 |
| Issue | 3 | Pages | 519-33 |
| PubMed ID | 25619653 | Mgi Jnum | J:219702 |
| Mgi Id | MGI:5629599 | Doi | 10.1016/j.neuron.2014.11.020 |
| Citation | Chakrabarty P, et al. (2015) IL-10 alters immunoproteostasis in APP mice, increasing plaque burden and worsening cognitive behavior. Neuron 85(3):519-33 |
| abstractText | Anti-inflammatory strategies are proposed to have beneficial effects in Alzheimer's disease. To explore how anti-inflammatory cytokine signaling affects Abeta pathology, we investigated the effects of adeno-associated virus (AAV2/1)-mediated expression of Interleukin (IL)-10 in the brains of APP transgenic mouse models. IL-10 expression resulted in increased Abeta accumulation and impaired memory in APP mice. A focused transcriptome analysis revealed changes consistent with enhanced IL-10 signaling and increased ApoE expression in IL-10-expressing APP mice. ApoE protein was selectively increased in the plaque-associated insoluble cellular fraction, likely because of direct interaction with aggregated Abeta in the IL-10-expressing APP mice. Ex vivo studies also show that IL-10 and ApoE can individually impair glial Abeta phagocytosis. Our observations that IL-10 has an unexpected negative effect on Abeta proteostasis and cognition in APP mouse models demonstrate the complex interplay between innate immunity and proteostasis in neurodegenerative diseases, an interaction we call immunoproteostasis. |
